IP Library Granted Patent US 7,780,689
Granted Patent B2
US 7,780,689 · App. 10/807,420 · Granted Aug 24, 2010

Bar-link drive system for a microkeratome

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,780,689
App. No.
10/807,420
Granted
Aug 24, 2010
Kind
B2
Abstract

A microkeratome 10 for use in ophthalmic surgery includes a bar-link drive 20 connected to a cutting-head 36 . A fixation ring 34 attaches to a patient's eye and is coupled to the bar-link drive 20 to the drive the cutting-head 36 at least partially across the fixation ring 34.

Claims (38)

1. A microkeratome for use in ophthalmic surgery comprising:

a slider-crank mechanism;

a cutting-head connected to the slider-crank mechanism;

a fixation ring coupled to the slider-crank mechanism; and

wherein the slider-crank mechanism moves the cutting-head at least partially across the fixation ring.

2. The microkeratome of claim 1 further including a controller connected to the slider-crank mechanism and fixation ring to control the movement of the cutting-head and the attachment of the ring to the patient's eye.

3. The microkeratome of claim 1 , wherein the connection of the cutting-head to the slider-crank mechanism includes a snap-on connector requiring less than 360° of rotation of the cutting-head relative to the slider-crank mechanism.

4. The microkeratome of claim 1 , wherein the slider-crank mechanism includes two (2) drive arms wherein each arm includes a link pin, each link pin including a slot such that one of the link pins mates with an elevation pin and the other pin mates with a flange of the fixation ring.

5. The microkeratome of claim 4 , wherein the elevation pin of the fixation ring acts to hold the other link pin above a slot of the fixation ring to improve the ease of assembly of the slider-crank mechanism onto the fixation ring.

6. The microkeratome of claim 4 wherein each arm includes a link pin, such that the link pins mate with structure formed on the fixation ring for guiding the slider-crank mechanism at least partially across the fixation ring.

7. The microkeratome of claim 6 wherein a pivot hole of the fixation ring includes an indentation for mating with a knob of the cutting-head for holding one of the link pins above a slot of the fixation ring.

8. The microkeratome of claim 1 , wherein the slider-crank mechanism includes a left/right selector that is alternately moveable between a start position of the slider-crank mechanism for a patient's left eye and a start position for a patient's right eye.

9. The microkeratome of claim 1 further including a cutting-head locator for angularly positioning an axis of rotation of cutting-head.

10. The microkeratome of claim 9 , wherein the cutting-head locator includes indents on opposite sides of the cutting-head for providing location for both left and right eyes of a patient.

11. The microkeratome of claim 9 , wherein the cutting-head locator includes resilient spring-like arms.

12. The microkeratome of claim 1 , wherein the fixation ring includes structure extending beyond a bottom-most part of an annular ring and raised above the bottom-most part of the annular ring for allowing the microkeratome to be rotated about a patient's eye without interference from the patient's nose, eyebrow, or cheek.

13. The microkeratome of claim 1 , wherein the slider-crank mechanism includes a pivot hole and a slot formed on the fixation ring.

14. The microkeratome of claim 13 , wherein the pivot hole and the slot are generally on opposing sides of the ring.

15. The microkeratome of claim 13 , wherein the pivot hole and the slot cause the cutting head to move in an arcuate path across the fixation ring.

16. The microkeratome of claim 13 , wherein the pivot hole and the slot cause the cutting head to move in a linear path across the fixation ring.

17. The microkeratome of claim 13 , wherein a length of the slot determines the length of translation of the slider-crank mechanism across the fixation ring.

18. The microkeratome of claim 1 wherein the slider-crank mechanism includes at least two slots formed on the fixation ring and a pair of rails for causing the cutting-head to move along a path defined by the rails across the fixation ring.

19. The microkeratome of claim 1 further including a translation stop internal to the slider-crank mechanism for allowing adjustable hinge-width.

20. The microkeratome of claim 1 further including a motor for automatically driving the cutting head at least partially across the fixation ring.

21. The microkeratome of claim 1 further including a motor for oscillating a blade assembly within the cutting head.

22. The microkeratome of claim 1 further including a first motor for automatically driving the cutting head assembly and a second motor for oscillating a blade assembly within the cutting head assembly.

23. A microkeratome for use in ophthalmic surgery comprising:

a slider-crank mechanism including a motor;

a cutting-head connected to the slider-crank mechanism;

a cutting blade assembly held within the cutting head;

a fixation ring coupled to the slider-crank mechanism; and

wherein the motor causes the slider-crank mechanism to move the cutting head assembly at least partially across the fixation ring and wherein the motor causes the cutting blade assembly to oscillate as the cutting head assembly translates across the fixation ring so that a flap of corneal tissue is formed on the eye.

24. The microkeratome of claim 23 further including a controller connected to the slider-crank mechanism and fixation to control the movement of the cutting-head and the attachment of the ring to the patient's eye.

25. The microkeratome of claim 23 , wherein the connection of the cutting-head to the slider-crank mechanism includes a snap-on connector requiring less than 360° of rotation of the cutting-head relative to the slider-crank mechanism.

26. The microkeratome of claim 23 , wherein the slider-crank mechanism includes a left/right selector that is alternately moveable between a start position of the slider-crank mechanism for a patient's left eye and a start position for a patient's right eye.

27. The microkeratome of claim 23 , wherein the slider-crank mechanism includes structure forming a pivot hole and a slot on the fixation ring for causing the cutting-head to move in an accurate path across the fixation ring.

28. The microkeratome of claim 23 , wherein the slider-crank mechanism includes at least two slots formed on the fixation ring and a pair of rails for causing the cutting-head to move along a path defined by the rails across the fixation ring.

29. The microkeratome of claim 23 further including a translation stop internal to the slider-crank mechanism for allowing adjustable hinge-width and an electronic translation stop.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0910 →
SECURITY AGREEMENT Recorded Aug 20, 2015
From: TECHNOLAS PERFECT VISION GMBH; DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036400/0711 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
MERGER Recorded Sep 18, 2009
From: TECHNOLAS GMBH OPHTHALMOLOGISCHE SYSTEME; 20/10 PERFECT VISION AG
To: TECHNOLAS PERFECT VISION GMBH
Reel/Frame 023253/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2009
From: BAUSCH & LOMB INCORPORATED
To: TECHNOLAS GMBH OPHTHALMOLOGISHE SYSTEME
Reel/Frame 023189/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2009
From: WAGNER, CHRISTOPHER
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 023142/0308 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2004
From: BARRILE-JOSEPHSON, CRAIG A.; DOBNER, MICHAEL H.; KIRCH, JAMES A.; HALECKI, PETER J.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 014888/0435 →